| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 44.74M | — |
| Operating expense | — | — |
| Net income | -100.70M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AGIO returned -14.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +21.6% |
| 1 year | -14.7% |
| 5 years | -25.9% |
| 10 years | -10.2% |
| All-time high | $122.02 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AGIO would be worth today ›No. Agios Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Agios Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol AGIO.
Agios Pharmaceuticals, Inc. is part of the Healthcare sector.
Agios Pharmaceuticals, Inc. has a market cap of 1.98B USD, based on the latest quote.
Agios Pharmaceuticals, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
